Taking people in Románia1. fázis
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of NBIM-1008 in Patients with Rheumatoid Arthritis
Key facts
- Where
- Bucharest és Cluj-Napoca, RomániaSee the 2 sites
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Románia
- Arensia Clinics S.R.L.Bucharest, RomániaTaking people
- Spitalul Clinic Judetean De Urgenta ClujCluj-Napoca, RomániaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Neurocrine Biosciences Inc.
- Trial code
- EU 2025-525113-22-00
- Record updated
- 2026. augusztus 10.